- English version
- Articles
- Life Sciences
- Genetic engineering
- Gene therapy of retinitis pigmentosa
Related posts
-
Scientists are closer to curing blindness with the help of gene therapy
Geneticists from the USA have found another use for the CRISPR genomic editor, using it to remove mutations from stem cells of people suffering from retinal degeneration.
28 January 2016 -
CRISPR/Cas9 system will be used to treat Leber's amaurosis
Biotech startup Editas Medicine will begin clinical trials of CRISPR/Cas9 technology for targeted editing of the human genome within the next two years.
06 November 2015 -
A new method of gene therapy for Leber's amaurosis
The results exceeded expectations: gene therapy not only prevents the development of blindness, but also restores almost completely lost vision.
06 October 2015 -
The effect of gene therapy for blindness may be temporary
Three research groups reported contradictory results of gene therapy for a rare form of hereditary blindness – Leber's amaurosis: in some, the effect was "long-lasting", while others registered a gradual deterioration in the condition of patients.
05 May 2015 -
Choroideremia gene therapy: success is developing
With the help of gene therapy, scientists from the University of Oxford were able to partially restore vision to six more patients with a hereditary progressive form of blindness – choroideremia.
17 January 2014